{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:05:58Z","timestamp":1777496758846,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K23AG071945"],"award-info":[{"award-number":["K23AG071945"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s40266-025-01185-6","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T10:36:32Z","timestamp":1738665392000},"page":"235-243","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Perioperative Anticholinergic Medication Use and Incident Dementia among Older Surgical Patients: a Retrospective Cohort Study using Real-World Data"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4424-925X","authenticated-orcid":false,"given":"Emma","family":"Holler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Molly","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corey","family":"Kalbaugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zina Ben","family":"Miled","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malaz","family":"Boustani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Ludema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"key":"1185_CR1","unstructured":"World Health Organization. Dementia facts. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia. Accessed 13 Dec 2024."},{"issue":"10248","key":"1185_CR2","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413\u201346. https:\/\/doi.org\/10.1016\/S0140-6736(20)30367-6.","journal-title":"Lancet"},{"key":"1185_CR3","unstructured":"Ghossein N KM, Lahkar AD. Anticholinergic medications. StatPearls Publishing. 2022. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK555893\/."},{"issue":"8","key":"1185_CR4","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1001\/jamainternmed.2019.0677","volume":"179","author":"CAC Coupland","year":"2019","unstructured":"Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic drug exposure and the risk of dementia: a nested case-control study. JAMA Intern Med. 2019;179(8):1084\u201393. https:\/\/doi.org\/10.1001\/jamainternmed.2019.0677.","journal-title":"JAMA Intern Med"},{"issue":"3","key":"1185_CR5","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","volume":"175","author":"SL Gray","year":"2015","unstructured":"Gray SL, Anderson ML, Dublin S, et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med. 2015;175(3):401\u20137. https:\/\/doi.org\/10.1001\/jamainternmed.2014.7663.","journal-title":"JAMA Intern Med"},{"issue":"5","key":"1185_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/2042098616658399","volume":"7","author":"SL Gray","year":"2016","unstructured":"Gray SL, Hanlon JT. Anticholinergic medication use and dementia: latest evidence and clinical implications. Ther Adv Drug Saf. 2016;7(5):217\u201324.","journal-title":"Ther Adv Drug Saf."},{"issue":"6","key":"1185_CR7","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1001\/jamaneurol.2016.0580","volume":"73","author":"SL Risacher","year":"2016","unstructured":"Risacher SL, McDonald BC, Tallman EF, et al. Association between anticholinergic medication use and cognition, brain metabolism, and brain atrophy in cognitively normal older adults. JAMA Neurol. 2016;73(6):721\u201332. https:\/\/doi.org\/10.1001\/jamaneurol.2016.0580.","journal-title":"JAMA Neurol"},{"issue":"2","key":"1185_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/ana.10639","volume":"54","author":"EK Perry","year":"2003","unstructured":"Perry EK, Kilford L, Lees AJ, Burn DJ, Perry RH. Increased Alzheimer pathology in Parkinson\u2019s disease related to antimuscarinic drugs. Ann Neurol. 2003;54(2):235\u20138. https:\/\/doi.org\/10.1002\/ana.10639.","journal-title":"Ann Neurol"},{"issue":"4","key":"1185_CR9","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3233\/jad-150290","volume":"46","author":"RJ Wurtman","year":"2015","unstructured":"Wurtman RJ. How anticholinergic drugs might promote Alzheimer\u2019s disease: more amyloid-\u03b2 and less phosphatidylcholine. J Alzheimers Dis. 2015;46(4):983\u20137. https:\/\/doi.org\/10.3233\/jad-150290.","journal-title":"J Alzheimers Dis"},{"key":"1185_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k1315","volume":"361","author":"K Richardson","year":"2018","unstructured":"Richardson K, Fox C, Maidment I, et al. Anticholinergic drugs and risk of dementia: case-control study. BMJ. 2018;361: k1315. https:\/\/doi.org\/10.1136\/bmj.k1315.","journal-title":"BMJ"},{"issue":"9920","key":"1185_CR11","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/s0140-6736(13)60688-1","volume":"383","author":"SK Inouye","year":"2014","unstructured":"Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet. 2014;383(9920):911\u201322. https:\/\/doi.org\/10.1016\/s0140-6736(13)60688-1.","journal-title":"Lancet"},{"issue":"7","key":"1185_CR12","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/gps.5508","volume":"36","author":"JV-B Pereira","year":"2021","unstructured":"Pereira JV-B, Aung Thein MZ, Nitchingham A, Caplan GA. Delirium in older adults is associated with development of new dementia: a systematic review and meta-analysis. Int J Geriatr Psychiatry. 2021;36(7):993\u20131003. https:\/\/doi.org\/10.1002\/gps.5508.","journal-title":"Int J Geriatr Psychiatry"},{"key":"1185_CR13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jss.2024.03.018","volume":"298","author":"S Mohanty","year":"2024","unstructured":"Mohanty S, Lindroth H, Timsina L, et al. A mediation analysis examining high risk, anticholinergic medication use, delirium, and dementia after major surgery. J Surg Res. 2024;298:222\u20139. https:\/\/doi.org\/10.1016\/j.jss.2024.03.018.","journal-title":"J Surg Res"},{"issue":"4","key":"1185_CR14","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/j.1532-5415.2012.03923.x","volume":"60","author":"CM Campanelli","year":"2012","unstructured":"Campanelli CM. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616\u201331. https:\/\/doi.org\/10.1111\/j.1532-5415.2012.03923.x.","journal-title":"J Am Geriatr Soc"},{"key":"1185_CR15","unstructured":"Indiana University Health. IU Health: about our system. https:\/\/iuhealth.org\/about-our-system. Accessed 15 Feb 2024."},{"key":"1185_CR16","unstructured":"Regenstrief Institute. The Indiana Network for Patient Care. https:\/\/www.regenstrief.org\/rds\/data\/. Accessed 15 Feb 2024."},{"issue":"2","key":"1185_CR17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/SLA.0b013e3181823485","volume":"248","author":"SF Khuri","year":"2008","unstructured":"Khuri SF, Henderson WG, Daley J, et al. Successful implementation of the Department of Veterans Affairs\u2019 National Surgical Quality Improvement Program in the private sector: the Patient Safety in Surgery study. Ann Surg. 2008;248(2):329\u201336. https:\/\/doi.org\/10.1097\/SLA.0b013e3181823485.","journal-title":"Ann Surg"},{"issue":"26","key":"1185_CR18","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1056\/NEJMp1802313","volume":"378","author":"AJH Kind","year":"2018","unstructured":"Kind AJH, Buckingham WR. Making neighborhood-disadvantage metrics accessible\u2014the neighborhood atlas. N Engl J Med. 2018;378(26):2456\u20138. https:\/\/doi.org\/10.1056\/NEJMp1802313.","journal-title":"N Engl J Med"},{"issue":"1","key":"1185_CR19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","volume":"36","author":"A Elixhauser","year":"1998","unstructured":"Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8\u201327. https:\/\/doi.org\/10.1097\/00005650-199801000-00004.","journal-title":"Med Care"},{"issue":"6","key":"1185_CR20","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1097\/MLR.0b013e31819432e5","volume":"47","author":"C van Walraven","year":"2009","unstructured":"van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care. 2009;47(6):626\u201333. https:\/\/doi.org\/10.1097\/MLR.0b013e31819432e5.","journal-title":"Med Care"},{"issue":"S1","key":"1185_CR21","first-page":"S142","volume":"61","author":"N Campbell","year":"2013","unstructured":"Campbell N, Maidment I, Fox C, Khan B, Boustani M. The 2012 update to the anticholinergic cognitive burden scale. J Am Geriatr Soc. 2013;61(S1):S142\u20133.","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"1185_CR22","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1111\/jgs.17183","volume":"69","author":"LMVR Moura","year":"2021","unstructured":"Moura LMVR, Festa N, Price M, et al. Identifying Medicare beneficiaries with dementia. J Am Geriatr Soc. 2021;69(8):2240\u201351. https:\/\/doi.org\/10.1111\/jgs.17183.","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"1185_CR23","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1097\/EDE.0b013e31823029dd","volume":"22","author":"CJ Howe","year":"2011","unstructured":"Howe CJ, Cole SR, Westreich DJ, Greenland S, Napravnik S, Eron JJ Jr. Splines for trend analysis and continuous confounder control. Epidemiology. 2011;22(6):874\u20135. https:\/\/doi.org\/10.1097\/EDE.0b013e31823029dd.","journal-title":"Epidemiology"},{"key":"1185_CR24","unstructured":"A Package for Survival Analysis in R. R package version 3.5-7. 2023. https:\/\/CRAN.R-project.org\/package=survival"},{"issue":"3","key":"1185_CR25","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.annepidem.2006.10.009","volume":"17","author":"R Li","year":"2007","unstructured":"Li R, Chambless L. Test for additive interaction in proportional hazards models. Ann Epidemiol. 2007;17(3):227\u201336. https:\/\/doi.org\/10.1016\/j.annepidem.2006.10.009.","journal-title":"Ann Epidemiol"},{"issue":"1","key":"1185_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1515\/em-2013-0005","volume":"3","author":"TJ VanderWeele","year":"2014","unstructured":"VanderWeele TJ, Knol MJ. A tutorial on interaction. Epidemiol Methods. 2014;3(1):33\u201372. https:\/\/doi.org\/10.1515\/em-2013-0005.","journal-title":"Epidemiol Methods"},{"issue":"4","key":"1185_CR27","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/m16-2607","volume":"167","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med. 2017;167(4):268\u201374. https:\/\/doi.org\/10.7326\/m16-2607.","journal-title":"Ann Intern Med"},{"issue":"5","key":"1185_CR28","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/ana.21509","volume":"64","author":"H Amieva","year":"2008","unstructured":"Amieva H, Le Goff M, Millet X, et al. Prodromal Alzheimer\u2019s disease: successive emergence of the clinical symptoms. Ann Neurol. 2008;64(5):492\u20138. https:\/\/doi.org\/10.1002\/ana.21509.","journal-title":"Ann Neurol"},{"issue":"1","key":"1185_CR29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3233\/jad-210105","volume":"83","author":"E Jones","year":"2021","unstructured":"Jones E, Aigbogun MS, Pike J, Berry M, Houle CR, Husbands J. Agitation in dementia: real-world impact and burden on patients and the healthcare system. J Alzheimers Dis. 2021;83(1):89\u2013101. https:\/\/doi.org\/10.3233\/jad-210105.","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"1185_CR30","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/qjmed\/hcw023","volume":"109","author":"P Gallagher","year":"2016","unstructured":"Gallagher P, Curtin D, de Si\u00fan A, et al. Antipsychotic prescription amongst hospitalized patients with dementia. QJM. 2016;109(9):589\u201393. https:\/\/doi.org\/10.1093\/qjmed\/hcw023.","journal-title":"QJM"},{"issue":"1","key":"1185_CR31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/nau.24536","volume":"40","author":"RR Dmochowski","year":"2021","unstructured":"Dmochowski RR, Thai S, Iglay K, et al. Increased risk of incident dementia following use of anticholinergic agents: a systematic literature review and meta-analysis. Neurourol Urodyn. 2021;40(1):28\u201337. https:\/\/doi.org\/10.1002\/nau.24536.","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"1185_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/j.1552-4604.1979.tb01612.x","volume":"19","author":"SM MacLeod","year":"1979","unstructured":"MacLeod SM, Giles HG, Bengert B, Liu FF, Sellers EM. Age- and gender-related differences in diazepam pharmacokinetics. J Clin Pharmacol. 1979;19(1):15\u20139. https:\/\/doi.org\/10.1002\/j.1552-4604.1979.tb01612.x.","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"1185_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.775","volume":"9","author":"SC Trenaman","year":"2021","unstructured":"Trenaman SC, Bowles SK, Andrew MK, Goralski K. The role of sex, age and genetic polymorphisms of CYP enzymes on the pharmacokinetics of anticholinergic drugs. Pharmacol Res Perspect. 2021;9(3): e00775. https:\/\/doi.org\/10.1002\/prp2.775.","journal-title":"Pharmacol Res Perspect"},{"issue":"2","key":"1185_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1177\/0091270007310385","volume":"48","author":"KL Bigos","year":"2008","unstructured":"Bigos KL, Pollock BG, Coley KC, et al. Sex, race, and smoking impact olanzapine exposure. J Clin Pharmacol. 2008;48(2):157\u201365. https:\/\/doi.org\/10.1177\/0091270007310385.","journal-title":"J Clin Pharmacol"},{"key":"1185_CR35","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.parkreldis.2019.06.022","volume":"65","author":"CT Hong","year":"2019","unstructured":"Hong CT, Chan L, Wu D, Chen WT, Chien LN. Antiparkinsonism anticholinergics increase dementia risk in patients with Parkinson\u2019s disease. Parkinsonism Relat Disord. 2019;65:224\u20139. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.06.022.","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-025-01185-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-025-01185-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-025-01185-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T14:01:59Z","timestamp":1741096919000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-025-01185-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1185"],"URL":"https:\/\/doi.org\/10.1007\/s40266-025-01185-6","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,4]]},"assertion":[{"value":"16 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Z.B.M. has a financial interest in DigiCare Realized and could benefit from the results of this research. M.B. serves as a Chief Scientific Officer and Co-Founder of Blue Agilis, and is the Chief Health Officer of DigiCare Realized. He has equity interest in Blue Agilis, DigiCare Realized, Preferred Population Health Management LLC, and MyShift (previously known as RestUp, LLC). He serves as an advisory board member for Acadia Pharmaceuticals, Eisai, Biogen, and Genentech. These conflicts have been reviewed by Indiana University and have been appropriately managed to maintain objectivity. The remaining authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was supported by National Institute on Aging no. K23AG071945.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The protocol for this retrospective cohort study was reviewed and approved by the Indiana University Institutional Review Board (no. 15767) prior to initiation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The data that support the findings of this study are available from the Regenstrief Institute, but restrictions apply to the availability of these data, which were used under a research agreement for the current study and are therefore not publicly available.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All authors contributed to the study concept and design. Data analysis was performed by E.H. The first draft of the manuscript was written by E.H. and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}